
Inter Parfums (IPAR) Stock Forecast & Price Target
Inter Parfums (IPAR) Analyst Ratings
Bulls say
Interparfums is positioned favorably because it has already delivered two quarters of sales growth, including 2Q U.S. sales up 18% reported and 17% organic, supported by stronger innovation, supply-chain recovery, and solid performance from GUESS and Donna Karan/DKNY. Its outlook is further strengthened by new growth drivers such as Longchamp entering fragrance, the expected 11-fragrance Solférino rollout in 2H26, and the potential for additional licensing agreements that could expand the long-term brand portfolio. The company also stands to benefit if fragrance-market growth accelerates or consumer adoption of upcoming launches exceeds expectations, with sustained market share gains and stronger European and Middle East conditions adding to the bullish case.
Bears say
Interparfums is facing a negative setup because its earnings trajectory is described as “descending” ahead of a sales catalyst that may not materially lift the stock, with much of the 2027 innovation cycle already embedded in valuation after the recent rally. Near-term fundamentals also look softer, as Europe and the Middle East account for about 34% and 8% of sales and remain weak, with 2Q26 Western Europe down 7% and the Middle East down 34%, implying muted topline growth through at least 2H26. At the same time, valuation has rerated to about 13.4x FY2 EV/EBITDA and 23.6x FY2 P/E, while gross margin fell roughly 65 bps from tariffs and mix pressure, leaving limited multiple upside and more downside if launches underdeliver.
This aggregate rating is based on analysts' research of Inter Parfums and is not a guaranteed prediction by Public.com or investment advice.
Inter Parfums (IPAR) Analyst Forecast & Price Prediction
Start investing in Inter Parfums (IPAR)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Inter Parfums (IPAR) Forecast
Inter Parfums (IPAR) Analyst Forecast & Price Prediction
Start investing in Inter Parfums (IPAR)
Order type
Buy in
Order amount
Est. shares
0 shares